Feb 9 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt :
* STILL BELIEVES BENEFIT TO RISK BALANCE OF ESMYA MEDICINE IS POSITIVE -SPOKESWOMAN
* CLINICAL DATA AVAILABLE CURRENTLY DO NOT SUPPORT CAUSAL CONNECTION BETWEEN ESMYA AND LIVER DAMAGE -SPOKESWOMAN
* RESTRICTIONS ON ESMYA WILL LEAD TO TEMPORARY LOSS OF REVENUE FROM MEDICINE UNTIL EXPECTED FINAL RULING IN MAY -SPOKESWOMAN
* RICHTER SHARES EXTEND FALLS, DOWN 3.4 PCT AT 1230 GMT, UNDERPERFORMING BLUE-CHIP INDEX Further company coverage: (Reporting by Gergely Szakacs)
Our Standards: The Thomson Reuters Trust Principles.